Seeking Alpha

MSTX
  Mast Therapeutics, Inc. - NYSEMKT

10/22/2014, 12:50 AM ET
  • jcri33 | Send Message 3 Nov 2013

    $MSTX holding strong above 50ma during short term beating for biotech overall. Highlights technical strength on verge of breakout to 200ma+!
    Reply
      MSTX vs. ETF Alternatives
      Company Description
      Mast Therapeutics Inc is a biopharmaceutical company developing novel therapies for serious or life-threatening diseases with significant unmet needs. Its pipeline includes MST-188 development programs in adjunctive thrombolytic therapy.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States